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Abstract In this study we describe the potential role
of autologous platelet gel and fibrin sealant in unilat-
eral total knee arthroplasty to improve the postoper-
ative range of motion and to reduce the incidence of
arthrofibrosis. Total knee arthroplasty is often associ-
ated with a considerable amount of post-operative
blood loss. Persistent limited motion directly after
surgery may ultimately result in arthrofibrosis. To
counteract these effects we investigated whether the
use of autologous derived platelet gel and fibrin sealant
would reduce postoperative blood loss, decrease the
impaired range of motion and the incidence of ar-
throfibrosis. All patients were consecutively operated
and assigned to the study or control groups. Study
group patients (n = 85) were treated with the applica-
tion of autologous platelet gel and fibrin sealant at the
end of surgery. Eighty patients were operated without
the use of platelet gel and fibrin sealant, and served as
the control group. The postoperative hemoglobin de-
crease, range of motion and length of hospitalization
were recorded. During a 5-month postoperative period
patients were followed to observe the incidence of ar-
throfibrosis. In patients in the treatment group the
hemoglobin concentration in blood decreased signifi-
cantly less when compared to the control group. They
also showed a superior postoperative range of motion
when compared to those of the control group
(P < 0.001). The incidence of arthrofibrosis and sub-
sequent forced manipulation was significantly less
(P < 0.001) in patients managed with platelet gel and
fibrin sealant. We conclude that peri-operatively ap-
plied platelet gel and fibrin sealant may improve the
range of motion after total knee arthroplasty, de-
creases the length of stay and may reduce the incidence
of arthrofibrosis.
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Introduction
Total knee arthroplasty is often associated with a con-
siderable amount of postoperative blood loss, necessi-
tating the transfusion of allogeneic blood products [3].
Relentless postoperative bleeding can contribute to
impaired outcomes after total knee arthroplasty, e.g.,
due to the development of wound haematoma and
seroma formation. Control of haemostasis following
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total knee arthroplasty is an important concern since
bleeding might lead to the formation of adhesions
and might even cause arthrofibrosis [6, 41]. Arthro-
fibrosis is rare, although its incidence may be up to 10%
[11, 17].
Optimization of strategies to improve outcome after
total knee arthroplasty aims to reduce postoperative
bleeding, to improve the range of motion and to de-
crease the incidence of arthrofibrosis. Platelet gel
(PG), a so-called buffy coat product prepared from
freshly drawn autologous blood, is a mixture of platelet
and leukocyte rich plasma being activated with
thrombin to produce a viscous gel cloth [8]. PG deliv-
ers concentrated platelets and the platelet growth
factors directly to wound sites, specifically platelet-
derived growth factor and transforming growth factor-
b, which both could contribute to improve wound
healing [5, 20].
Treatment with autologous, bed-side prepared
blood components, in order to control bleeding and
stimulate wound healing, is a relatively new concept
and might reduce the development of tissue adhesions.
Fibrin sealants prepared from platelet poor plasma
(PPP) and also activated with thrombin, have been
used in a variety of surgical procedures in order to
control bleeding, with a subsequent reduction in post-
operative tissue adhesions [24, 33, 35].
In orthopaedic surgery, PG has mostly been used
in spinal fusion operations to enhance fusion, since
platelets stimulate the activity of bone cells, based on
their particular relevance to bone growth and therefore
accelerate bone growth [34, 37]. Recently, PG has also
been used to control bleeding [7, 10]. Fibrin sealants
have mainly been used as reconstructive supportive
surgical tools [30]. PG and fibrin sealants have also
been cited as useful in soft tissue tendon repairs, [1, 2]
and as a supportive tool in bone regeneration [9, 42].
In this study we assessed the potential of PG and
fibrin sealant to act as a haemostatic-surgical tool
during total knee arthroplasty and if it might improve
the range of motion and probably decrease the inci-
dence of arthrofibrosis up to 5 months after surgery.
Materials and methods
In this observational study, 165 patients who were
scheduled for primary unilateral total knee arthroplasty
were included. All patients were consecutively operated
and underwent the same surgical procedure performed
by the same two surgeons (RD or MES). The indication
in all patients for total knee arthroplasty was osteo-
arthritis of the knee. Eighty-five patients were treated
with PG and fibrin sealant and a further 80 patients
served as untreated controls. They were all operated
under a standardized spinal anesthesia and fluid
regimen protocol. A tourniquet was used in all cases.
Patients with a preoperative-hemoglobin level less than
12 g/dl or know coagulation disorders were excluded
from the study.
The autologous blood components were prepared
from a unit of freshly drawn whole blood (approxi-
mately 350 ml) using an infusion line, which was been
placed in the medial cubital vein into a bag containing
anticoagulant to avoid blood clothing. A blood cell
separator, (ElectaTM, Sorin Group, Mirandola, Italy),
sequestered the whole blood in fractions of platelet
rich plasma (PRP) and PPP [7]. To collect the PRP and
PPP, a single centrifugation procedure with a 125 ml
Latham bowl was performed. The centrifugation pro-
cess consisted of a 5,400 rpm (1,660g force) and a
2,400 rpm cycle (305g force) for 15 and 3 min,
respectively.
A medial para-patellar approach was used, averting
the patella laterally. With the use of a tourniquet, ce-
mented and non-cemented cruciate-sparing prostheses
were implanted (Advantim and Advance, Wright
Medical Products, Arlington, TN and Somas, The
Netherlands; LCS, Johnson and Johnson DePuy, Pis-
cataway, NJ). After implantation of the prosthesis the
tourniquet was deflated, and primary haemostasis of
major blood vessels was achieved with electrocautery.
Before wound closure, the knee soft tissues and joint
were rinsed with saline solution to remove all debris.
PG and fibrin sealants were then produced from PRP
and PPP, respectively, by the addition of calcified
thrombin to set up a PG blood cloth and create a sticky
fibrin sealant. Autologous thrombin was produced
from PRP by mixing 6 ml of PRP with 0.25 ml of cal-
cium chloride 10%. PG was created by mixing PRP
with autologous thrombin at a ratio of 4:1. Fibrin
sealant was produces by mixing 10 ml PPP with 1 ml
autologous thrombin in the aerosol delivery system
(Aerosol Ratio Applicator, Micromedics Inc., St Paul,
MN, USA).
PG and fibrin sealants were applied to dried wound
sites in order to promote adherence of the components
to the tissues. In the study group, the knee was posi-
tioned in approximately 90 flexion to expose the knee
cavity, femoral and tibial components. Ten millilitre of
PG was initially injected in the back of the knee cavity
to plug the bone marrow sinusoids (Fig. 1), the pos-
terior recess, the gutters and the raw exposed surfaces
of the femur and tibia.
Thereafter, the wound area was retracted and 10 ml
of fibrin sealant was applied to the dried tissues by a
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double syringe technique and delivered by aerosol
topical spraying at a distance of 15 cm (Fig. 2) to
prevent the formation of hematoma and seromata. The
wound was closed in layers, with the knee in approxi-
mately 90 flexion. After closure of the knee capsula,
another 10 ml of PG was injected between the stitches
on the repaired extensor mechanism and the prepa-
tellar fat (Fig. 3). The closed capsula and the subcu-
taneous tissues were again dried and sprayed with 8 ml
of fibrin sealant, and the skin was closed with skin
staples.
In all patients, the knee incision was dressed post-
operatively with compressing bandages and rehabili-
tation was started at the day of surgery, with constant
passive motion that was increased daily within the
patient’s pain tolerance. Postoperative pain relief was
achieved using a standard protocol, (paracetamol 3 g
daily and naproxen 500 mg twice daily for the first two
postoperative days. If necessary, 10–20 mg piritramide
was given).
All patients received thrombosis prophylaxis, before
the operation until 6 weeks postoperatively, via a
subcutaneous injection of 20 mg nadroparin (Fraxip-
arine).
Decreases in postoperative hemoglobin levels, the
range of motion (expressed as maximum degrees of
flexion of the knee joint) during the first 5 days and at
discharge, and the incidence of postoperative arthro-
fibrosis were all recorded. We defined arthrofibrosis as
(painful) stiffness with scarring of soft tissue, a limited
flexion (<80) and patellofemoral immobility, with no
heterotopic bone formation. The ward physician or
nurse practitioner was blinded for the study during the
daily determination of the postoperative range of
motion.
Length of hospital stay was recorded in all patients.
Patients were discharged if they met all of the follow-
ing criteria: joint function recovery with a flexion >90,
absence of wound leakage, no wound healing distur-
bances and no signs of infection.
Statistical analyses were performed using SAS sta-
tistical software (SAS Institute, Cary, NC, USA, 2003).
Categorical data are expressed as a percentage with
165 patients included and measured data are expressed
as mean ± standard deviation. A univariate analysis
was performed by means of Fisher’s exact test on all
categorical data and the Student’s t-test on all mea-
sured data. Differences between means were analyzed
using the Student’s t-test and Satterthwaite’s approxi-
mation that does not assume equal variances [16]. A
two-sided P value of 0.05 or less was considered to be
statistically significant.
Fig. 1 Injection of platelet gel in the back of the knee cavity
after prosthetic implant
Fig. 2 Application of fibrin sealant to the dried tissues by
aerosol topical spraying with a double syringe technique
Fig. 3 Injection of platelet gel between the stitches of the
repaired extensor mechanism and the pre-patellar fat
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Results
The mean age of the PG and fibrin sealants treated
patients (n = 85) and control patients (n = 80) were
similar (69.4 ± 9.1 and 67.4 ± 9.9, respectively). The
distribution of gender was 68% females in the treatment
group and 72% in the control (not statistically different).
The distributions for cementless and cemented pros-
thetic implants were similar for both groups.
The pre-operative hemoglobin value was also com-
parable in both groups (Table 1). Postoperative
hemoglobin values of patients receiving PG and fibrin
sealant dropped significantly less in the study group
(P < 0.001) when compared to the control patients (2.5
vs. 5.2 g/dl, respectively).
Range of motion data are shown in Fig. 4. Func-
tional knee recovery occurred significantly earlier in
treated patients. At the fourth postoperative day the
functional range of motion was 82.4 ± 9and 66.1 ± 13
(P < 0.001) for the PG/fibrin sealant patients and
control patients, respectively. By the fifth postopera-
tive day the range of motion was 92.4 ± 8 and
79.2 ± 9, respectively (P < 0.001). Further analysis
revealed that patients with cemented implants and
treated with PG/fibrin sealant, showed the same sta-
tistical difference when compared to the same patients
in whom no PG/fibrin sealant was employed with re-
gard to development in the ROM (P < 0.001).
None of the patients underwent TKA for rheuma-
toid arthritis. In Table 2 the incidence of arthrofibrosis,
up to 5 months after surgery is shown. The preopera-
tive active flexion was not statistical different for both
patient groups. The criterion for arthrofibrosis was met
in all patients (flexion 70 and 79 for treated and
control patients, respectively). Arthrofibrosis occurred
only patients who received a cemented prosthesis.
This complication arised only in two patients in whom
PG and fibrin sealants were applied, whereas eighth
control patients developed arthrofibrosis (P < 0.001)
(Table 2). After forced mobilization the active flexion
improved by 28 and 24% for treated and control
patients, respectively.
The improved range of motion and reduced bleed-
ing contributed to a shorter hospitalization time in
treated patients (6.9 ± 1.4 days) compared to the con-
trol group (8.3 ± 2.9 days) (P < 0.001).
Discussion
Total knee arthroplasty is associated with major blood
loss particularly in the postoperative period following
the release of the tourniquet. In this study, we found
that in patients treated with the exogenous application
of PG and fibrin sealant, the drop in hemoglobin was
less.
Various reports from clinical and experimental
studies have shown that the use of fibrin sealants to
seal off tissue capillaries can be an effective measure to
reduce the incidence of bleeding and oozing after
surgical interventions. Both experimental and clinical
data have demonstrated the efficacy of wound sealing
[25, 36]. However, only few clinical studies with pa-
tients undergoing total knee arthroplasty in combina-
tion with haemostatic agents to control bleeding have
been published. Levi et al. [18] and Wang [40] used
commercially available topical sprays, to reduce
bleeding. However, the effect of reduced bleeding on
the postoperative range of motion and the occurrence
of arthrofibrosis was not investigated.
Arthrofibrosis after total knee arthroplasty, which
has been variably referred to as stiffness and limited
motion, is a disabling complication. There are only a few
studies, which show the prevalence of arthrofibrosis to
vary from 1 to 11% [11, 17, 32]. These differences may
be explained by differences in the definitions. In the
Table 1 Patient characteristics and type of knee prosthesis used
Description Treatment group
(n = 85)
Control group
(n = 80)
Age (years) 69.4 ± 9.1 67.4 ± 9.9
Gender (F/M) 58/27 58/22
% Cemented 74 73
Pre-op hemoglobin (g/
dl)
13.6 ± 1.1 13.7 ± 1.1
Post-op EC-T (Units) 0.17 ± 0.6 0.52 ± 0.9*
Discharge hemoglobin
(g/dl)
10.9 ± 1.0 10.5 ± 1.1
The values are given as mean and the standard deviation
EC-T erythrocyte concentrate transfusion
* P < 0.001. The mean EC-T was significantly higher in the
control group
*
40
50
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80
90
100
day 2 day 3 day 4 day 5
Post-operative day
R
O
M
Control PG+FS
*
Fig. 4 Development of the range of motion in the postoperative
period. ROM range of motion, PG + FS platelet gel and fibrin
sealant. *P < 0.001
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majority of these studies, arthrofibrosis was defined as a
flexion contraction. In this study we used the criteria as
defined by Maloney [19]. Others have used slightly
different definitions [4, 23] for arthrofibrosis or stiffness.
Arthrofibrosis may be caused by numerous factors,
including impaired range of motion pre-operatively,
surgical technical problems, and inadequate postoper-
ative rehabilitation with limiting motion until wound
healing occurs or a biological predilection [11, 14, 22, 26,
28]. Some patients may be predisposed to extensive scar
tissue formation as a response to the tissue trauma,
which occurs during the surgical intervention. Never-
theless, in our study we could not detect any underlying
factors in either patient group that would increase the
risk for the development of arthrofibrosis.
In addition to the prevention of bleeding and ooz-
ing, sealing of surgical tissues also may contribute to
reduced post-surgical adhesion [13, 39]. Sheppard and
associates [33] demonstrated in a long-term model that
animals treated with wound sealing had significantly
less high-grade adhesions. In addition, sealing of
wound tissues might decrease inflammatory processes
following surgical interventions, and thus to a reduc-
tion of adhesion formation [12, 38].
Autologous blood sequestration of whole blood and
the preparation of PG in the peri-operative period is a
simple and highly reproducible procedure creating a
biological carrier of both the patient’s own platelets
and leucocytes [15]. PRP is a buffy coat product, con-
taining high concentrations of platelets with at least six
platelet growth factors inside the a-granules, each
having a specific function during wound repair [21].
Upon the creation of a PG, the addition of thrombin
activates platelets and they subsequently release their
granule contents in a way that various growth factors
interact with specific receptor cells and thus initiate the
healing process [31]. In addition, due to the activation
process more platelets are attracted to the wound site
to augment the natural healing processes. PRP also
contains a high concentration of non-activated func-
tional neutrophilic white blood cells. These white
blood cells contribute to the inhibitory effects of
inflammatory processes [27] and may act as anti-
microbial agents. Based on the results of applying
wound sealants in a variety of surgical settings, we
developed in this study a combination of exogenously
applied PG and fibrin sealant for total knee arthro-
plasty. The preparation of the syringes for PG delivery
and fibrin sealant use during wound closure were pre-
pared by a person educated and trained in autologous
platelet growth factor delivery and fibrin sealant
application techniques. This person scrubbed up to the
surgical team at the end of the procedure to assist
during the application of the components. Worth
mentioning is the fact that due to this individual, the
total surgical time was hardly increased.
Particular emphasis was to reduce postoperative
bleeding, to achieve an earlier increased range of mo-
tion after surgery, to minimize soft tissue adhesions
and to reduce the development of arthrofibrosis.
Patients treated with PG and fibrin sealant could
achieve a significantly greater range of motion when
compared to non-treated patients. In another study, a
similar increased range of motion in patients treated
with PG and fibrin sealants has been reported [10]. As
noted in the literature, the preoperative range of mo-
tion is a good predictor of the postoperative range of
motion [19, 29] and is the most important variable in
determining the patient’s postoperative flexion. A total
knee arthroplasty will not improve flexion in patients
who have preoperatively a stiff knee. In this study we
observed that the postoperative range of motion of the
knee was always inferior to the preoperative range of
motion. Furthermore, we could not demonstrate an
effect of cemented versus cementless prosthesis with
regard to the development in the ROM in this study.
Therefore, the effect of PG/fibrin sealant application
contributed to an improved outcome, regardless the
type of prosthesis used.
Another effect by applying PG and fibrin sealant
was that the total admission time was shortened by
1.4 ± .0.4 days (P < 0.001), when the same criteria
for discharge were used for both groups. These data
suggest that the application of autologous PG may
contribute to better wound tissue healing. Also the
coverage of oozing wound sites may minimize adhesion
and soft tissue contractions, probably contributing
to a lower incidence of arthrofibrosis in the treated
Table 2 Knee flexion data in patients with arthrofibrosis
Pre-op flex Post-op flex Weeks after surgery Post FM flex
Control (n = 8) 113 ± 27 79 ± 11 14 ± 6 98 ± 10
PG + FS (n = 2) 98 ± 8 70 ± 6 8 ± 3 90 ± 4
Data are given in degrees (mean ± SD)
PG + FS platelet gel and fibrin sealant, Pre-op flex preoperatively flexion, Post-op flex postoperatively flexion, Post FM flex post-
operative flexion after forced knee mobilization/manipulation under epidural anesthesia at the first visit after the procedure
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patients. Patients, in whom arthrofibrosis was diag-
nosed, were later subjected to forced mobilization
under general anesthesia, which resulted in increased
mobility of the knee joint in all patients.
In conclusion, we have shown that peri-operative ap-
plied PG and fibrin sealant in total knee arthroplasty may
contribute to an earlier and increased range of motion of
the knee joint and may reduce the incidence of arthro-
fibrosis associated with total knee arthroplasty. The
application of autologous growth factors in orthopaedic
surgery could be developed into a routine procedure.
Future randomized controlled studies are now warranted
to elucidate the potential effect of PG and fibrin sealant
in a variety of orthopaedic surgical procedures.
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